Elevance Health Inc. (ELV)
NYSE: ELV · IEX Real-Time Price · USD
537.26
-2.42 (-0.45%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Elevance Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1999 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 6,526 | 7,387 | 4,880 | 5,741 | 4,937 | 3,934 | 3,609 | 4,075 | 2,114 | 2,152 | Upgrade
|
Short-Term Investments | 29,843 | 26,905 | 28,148 | 24,992 | 20,685 | 18,206 | 20,993 | 18,647 | 18,381 | 19,394 | Upgrade
|
Cash & Cash Equivalents | 36,369 | 34,292 | 33,028 | 30,733 | 25,622 | 22,140 | 24,602 | 22,723 | 20,494 | 21,546 | Upgrade
|
Cash Growth | 6.06% | 3.83% | 7.47% | 19.95% | 15.73% | -10.01% | 8.27% | 10.87% | -4.88% | 5.76% | Upgrade
|
Receivables | 17,865 | 16,044 | 13,440 | 10,958 | 10,391 | 9,301 | 8,452 | 8,397 | 7,024 | 6,943 | Upgrade
|
Other Current Assets | 5,795 | 5,281 | 4,654 | 4,060 | 3,020 | 2,880 | 3,209 | 3,195 | 3,344 | 3,459 | Upgrade
|
Total Current Assets | 60,029 | 55,617 | 51,122 | 45,751 | 39,033 | 34,321 | 36,263 | 34,315 | 30,862 | 31,948 | Upgrade
|
Property, Plant & Equipment | 4,359 | 4,316 | 3,919 | 3,483 | 3,133 | 2,735 | 2,175 | 1,978 | 2,020 | 1,944 | Upgrade
|
Long-Term Investments | 6,983 | 6,437 | 5,857 | 4,847 | 4,763 | 4,246 | 3,938 | 2,796 | 2,630 | 2,232 | Upgrade
|
Goodwill and Intangibles | 35,590 | 34,698 | 34,843 | 31,096 | 29,174 | 29,511 | 27,599 | 25,526 | 25,720 | 25,040 | Upgrade
|
Other Long-Term Assets | 1,967 | 1,687 | 1,719 | 1,438 | 1,350 | 758 | 565 | 467.9 | 485.4 | 512.3 | Upgrade
|
Total Long-Term Assets | 48,899 | 47,138 | 46,338 | 40,864 | 38,420 | 37,250 | 34,277 | 30,768 | 30,856 | 29,729 | Upgrade
|
Total Assets | 108,928 | 102,755 | 97,460 | 86,615 | 77,453 | 71,571 | 70,540 | 65,083 | 61,718 | 61,676 | Upgrade
|
Accounts Payable | 23,021 | 21,203 | 18,488 | 16,852 | 13,040 | 13,214 | 13,583 | 13,080 | 12,263 | 12,095 | Upgrade
|
Deferred Revenue | 1,402 | 1,112 | 1,153 | 1,259 | 1,017 | 902 | 860 | 971.9 | 1,146 | 1,078 | Upgrade
|
Current Debt | 1,874 | 1,765 | 1,874 | 700 | 2,298 | 1,994 | 2,550 | 1,368 | 540 | 1,024 | Upgrade
|
Other Current Liabilities | 15,494 | 15,616 | 13,370 | 10,642 | 7,177 | 5,855 | 6,363 | 5,874 | 5,145 | 4,556 | Upgrade
|
Total Current Liabilities | 41,791 | 39,696 | 34,885 | 29,453 | 23,532 | 21,965 | 23,356 | 21,294 | 19,093 | 18,753 | Upgrade
|
Long-Term Debt | 23,246 | 22,349 | 21,157 | 19,335 | 17,787 | 17,217 | 17,382 | 14,359 | 15,325 | 14,020 | Upgrade
|
Other Long-Term Liabilities | 4,486 | 4,380 | 5,290 | 4,628 | 4,406 | 3,848 | 3,299 | 4,330 | 4,257 | 4,653 | Upgrade
|
Total Long-Term Liabilities | 27,732 | 26,729 | 26,447 | 23,963 | 22,193 | 21,065 | 20,681 | 18,688 | 19,581 | 18,672 | Upgrade
|
Total Liabilities | 69,523 | 66,425 | 61,332 | 53,416 | 45,725 | 43,030 | 44,037 | 39,983 | 38,674 | 37,425 | Upgrade
|
Total Debt | 25,120 | 24,114 | 23,031 | 20,035 | 20,085 | 19,211 | 19,932 | 15,727 | 15,865 | 15,044 | Upgrade
|
Debt Growth | 4.17% | 4.70% | 14.95% | -0.25% | 4.55% | -3.62% | 26.74% | -0.87% | 5.45% | 3.81% | Upgrade
|
Retained Earnings | 31,749 | 29,647 | 27,088 | 23,802 | 22,573 | 19,988 | 18,054 | 16,561 | 14,779 | 14,014 | Upgrade
|
Comprehensive Income | -1,313 | -2,490 | -178 | 150 | -296 | -986 | -101 | -267.9 | -292.6 | 171.9 | Upgrade
|
Shareholders' Equity | 39,306 | 36,243 | 36,060 | 33,199 | 31,728 | 28,541 | 26,503 | 25,100 | 23,044 | 24,251 | Upgrade
|
Net Cash / Debt | 11,249 | 10,178 | 9,997 | 10,698 | 5,537 | 2,929 | 4,670 | 6,996 | 4,630 | 6,502 | Upgrade
|
Net Cash / Debt Growth | 10.52% | 1.81% | -6.55% | 93.21% | 89.04% | -37.28% | -33.25% | 51.10% | -28.79% | 10.57% | Upgrade
|
Working Capital | 18,238 | 15,921 | 16,237 | 16,298 | 15,501 | 12,356 | 12,907 | 13,021 | 11,770 | 13,195 | Upgrade
|
Book Value Per Share | 167.29 | 151.75 | 148.57 | 133.49 | 125.13 | 110.35 | 103.22 | 95.28 | 88.27 | 89.84 | Upgrade
|